Oxford Professor, Andrew Nicholson, to be Honored for Lifetime Scientific Achievement in Lung Cancer Translational Research

DENVER – Professor Andrew Nicholson will be recognized by the International Association for the Study of Lung Cancer (IASLC) with the Mary J. Matthews Pathology/Translational Research award at the IASLC 2019 World Conference on Lung Cancer (WCLC) in Barcelona, Spain. Nicholson, a professor in respiratory pathology, will be honored for his lifetime scientific achievements in pathology-translational research of thoracic malignancies.

Dr. Nicholson trained in medicine at Oxford University and St. Bartholomew’s Medical School, and then specialized in thoracic pathology at the Royal Brompton Hospital. He is an honorary professor in respiratory pathology at the National Heart and Lung Institute, Imperial College in London.

Dr. Nicholson’s research has been referred to in over 300 cases each year, mainly cancer related, from clinicians and other pathologists both nationally and internationally. His research interests are common and rare lung cancers, mesotheliomas, thymic tumors and other thoracic diseases such as interstitial lung disease.

Dr. Nicholson is the past chair of the IASLC Pathology Panel and a long-standing member of the IASLC Staging and Prognostic Factors Committee and the IASLC Membership Committee. He was on the Specialist Advisory Panel for the Royal College of Pathologists for the past decade and is president-elect of the British Division of the International Academy of Pathologists.

Dr. Nicholson co-authored the medical text Pathology of the Lung, second and third editions, with Byran Corrin. He was a volume editor of the 2015 World Health Organization Classification of Lung, Pleura, Thymus and Heart Tumors. He is also the author of the AFIP Atlas of Tumor Pathology: Tumors of the Lower Respiratory Tract.

Professor Nicholson will be honored on Sept. 7, 2019 at the Opening Ceremony of the IASLC 2019 WCLC in Barcelona, Spain. The IASLC WCLC is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 7,000 researchers, physicians, and specialists from more than 100 countries. The IASLC 2019 WCLC will take place in Barcelona, Spain Sept. 7-10, 2019. For more information on the IASLC 2019 WCLC, visit https://wclc2019.iaslc.org/.

About the WCLC:

The WCLC is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 countries. The goal is to increase awareness, collaboration and understanding of lung cancer, and to help participants implement the latest developments across the globe. The conference will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more information, visit wclc2019.iaslc.org.
 

About the IASLC:

The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 6,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information. 

Back to listing